Recently, Δ133p53β was shown to enhance the cancer cell stemness potential of breast cancer cells and to regulate the expression of SOX2, OCT3/4, and NANOG, key cell pluripotency/reprogramming genes, resulting in increased mammosphere-forming ability and metastatic potential of cancer cells. This evidence concerns the gene SOX2 and cancer.